Search by Drug Name or NDC

    NDC 51991-0982-01 Zolpidem Tartrate 12.5 mg/1 Details

    Zolpidem Tartrate 12.5 mg/1

    Zolpidem Tartrate is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Breckenridge Pharmaceutical, Inc.. The primary component is ZOLPIDEM TARTRATE.

    Product Information

    NDC 51991-0982
    Product ID 51991-982_1e807e86-f6f0-47bf-b992-bb7cc05836be
    Associated GPIs 60204080100420
    GCN Sequence Number 059697
    GCN Sequence Number Description zolpidem tartrate TAB MPHASE 12.5 MG ORAL
    HIC3 H2E
    HIC3 Description SEDATIVE-HYPNOTICS,NON-BARBITURATE
    GCN 25457
    HICL Sequence Number 007842
    HICL Sequence Number Description ZOLPIDEM TARTRATE
    Brand/Generic Generic
    Proprietary Name Zolpidem Tartrate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Zolpidem Tartrate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 12.5
    Active Ingredient Units mg/1
    Substance Name ZOLPIDEM TARTRATE
    Labeler Name Breckenridge Pharmaceutical, Inc.
    Pharmaceutical Class Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA213592
    Listing Certified Through n/a

    Package

    NDC 51991-0982-01 (51991098201)

    NDC Package Code 51991-982-01
    Billing NDC 51991098201
    Package 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-982-01)
    Marketing Start Date 2020-12-17
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.14043
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description ZOLPIDEM TART ER 12.5 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis